We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AIFORIA.HE

Price
3.20
Stock movement up
+0.02 (0.63%)
Company name
Aiforia Technologies Oyj
Exchange
(HE
,
Currency
EUR
)
Sector
Healthcare >
Health Information Services
Market cap
101.77M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-32.49%
3 year return
-12.10%
5 year return
-
10 year return
-
Last updated: 2025-08-27

DIVIDENDS

AIFORIA.HE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.19
Daily high3.27
Daily low3.16
Daily Volume55K
All-time high5.53
1y analyst estimate4.20
Beta0.27
EPS (TTM)-
Dividend per share-
Ex-div date-
Next earnings date28 Aug 2025

Downside potential

Loading...
Downside potential data
AIFORIA.HES&P500
Current price drop from All-time high-42.13%-2.53%
Highest price drop-45.03%-56.47%
Date of highest drop28 Dec 20229 Mar 2009
Avg drop from high-27.84%-11.04%
Avg time to new high74 days12 days
Max time to new high858 days1805 days
COMPANY DETAILS
AIFORIA.HE (Aiforia Technologies Oyj) company logo
Marketcap
101.77M
Marketcap category
Small-cap
Description
Aiforia Technologies Oyj, together with its subsidiary Aiforia Inc., equips pathologists and scientists in preclinical, clinical, and academic labs with deep learning artificial intelligence (AI) software in Finland, the rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology workflow; and Aiforia Create, an agile solution to develop an AI model for image analysis application. The company's products are used for the treatment of Parkinson's disease, organ transplantation, and liver and inflammatory bowel diseases. It serves academic institutes and pharmaceutical companies through direct and partner sales. Aiforia Technologies Oyj was incorporated in 2013 and is headquartered in Helsinki, Finland.
Employees
77
Investor relations
-
CEO
Country
Finland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found